Safety of First-line Chemotherapy with Metronomic Single-agent Oral Vinorelbine in Elderly Patients with NSCLC

The optimal therapeutic use of metronomic vinorelbine has not yet been defined. We aimed to assess the safety of metronomic oral vinorelbine in first-line treatment of elderly patients with advanced lung cancer who were unfit for polychemotherapy. Progression-free survival, response rate and overall...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anticancer research 2017-06, Vol.37 (6), p.3189
Hauptverfasser:	Mencoboni, Manlio, Filiberti, Rosa Angela, Taveggia, Paola, Del Corso, Lisette, Del Conte, Alessandro, Covesnon, Maria Grazia, Puccetti, Cheti, Donati, Sara, Auriati, Laura, Amoroso, Domenico, Camerini, Andrea
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Metronomic Administration, Oral Age Factors Aged Aged, 80 and over Antineoplastic Agents, Phytogenic - administration & dosage Antineoplastic Agents, Phytogenic - adverse effects Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - pathology Disease-Free Survival Feasibility Studies Female Humans Italy Kaplan-Meier Estimate Lung Neoplasms - drug therapy Lung Neoplasms - mortality Lung Neoplasms - pathology Male Medication Adherence Pilot Projects Time Factors Treatment Outcome Vinblastine - administration & dosage Vinblastine - adverse effects Vinblastine - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!